Kallikrein-kinin system in hepatic experimental models

Peptides

Volumn 26, Issue 8, 2005, Pages 1301-1307

  Kouyoumdjian, Maria ^a   Nagaoka, Márcia Regina ^a   Borges, Durval Rosa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ACE; Bradykinin; Bradykinin receptor; Galectin; Kallikrein; Portal hypertension

Indexed keywords

BRADYKININ ANTAGONIST; BRADYKININ[1-8]; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; ICATIBANT; KININOGEN; NAPROXEN; PREKALLIKREIN;

CIRCULATION; CONFERENCE PAPER; DRUG POTENCY; FATTY LIVER; HUMAN; HYDROLYSIS; KALLIKREIN KININ SYSTEM; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER NECROSIS; LIVER REGENERATION; LIVER SINUSOID; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; BRADYKININ; DISEASE MODELS, ANIMAL; HUMANS; KALLIKREIN-KININ SYSTEM; KALLIKREINS; LIVER; RECEPTORS, CELL SURFACE;

EID: 22544458438     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.03.024     Document Type: Conference Paper

References (64)

1. E. Bhunchet, and K. Wake The portal lobule in rat liver fibrosis: a re-evaluation of the liver unit Hepatology 27 1998 481 487
2. D.R. Borges, A.H. Gordon, J.A. Guimarães, and J.L. Prado Rat plasma kallikrein clearance by perfused rat liver Braz J Med Biol Res 18 1985 187 194
3. D.R. Borges, and A.H. Gordon Kininogen and kininogenase synthesis by the liver of normal and injured rats J Pharm Pharmacol 28 1976 44 48
4. D.R. Borges, and M. Kouyoumdjian The recognition site for hepatic clearance of plasma kallikrein is on its heavy chain and is latent on prokallikrein J Hepatol 16 1992 115 121
5. D.R. Borges, E.A. Limaos, J.L. Prado, and A.C. Camargo Catabolism of vasoactive polypeptides by perfused rat liver Naunyn Schmiedebergs Arch Pharmacol 295 1976 33 40
6. D.R. Borges, M.R. Nagaoka, F.O. Teixeira, P. Minary, and M. Kouyoumdjian Chemical aggression or inflammatory and regenerative stimuli do not induce bradykinin B1 receptor expression in the liver Liver Int 24 2004 33
7. D.R. Borges, J.L. Prado, and J.A. Guimarães Characterization of a kinin-converting arylamino-peptidase from human liver N-S Arch Pharmacol 281 1974 403 414
8. D.R. Borges, Sampaio CAM, P. da la Llosa, and J.L. Prado The liver is the main organ to clear plasma and tissue kallikreins from plasma in vivo Adv Exp Biol Res 198A 1986 229 233
9. D.R. Borges, M.E. Webster, J.A. Guimarães, and J.L. Prado Synthesis of prekallikrein and metabolism of plasma kallikrein by perfused rat liver Biochem Pharmacol 30 1981 1065 1069
10. D.R. Borges The liver and the kallikrein-kinin system: a brief review Agents Actions Suppl 36 1992 171 176
11. V.B. Braulio, M. Kouyoumdjian, S. Zucoloto, J. Figueiredo, and D.R. Borges Plasma-kallikrein clearance during liver regeneration after partial hepatectomy in the rat Liver 18 1998 371 377
12. N.J. Brown, J.H. Nadeau, and D.E. Vaughan Selective stimulation of tissue-type plasminogen activator (t-PA) "in vivo" by infusion of bradykinin Thromb Haemost 77 1997 522 525
13. A.H. Campos, and J.B. Calixto Mechanisms involved in the contractile responses of kinins in rat portal vein rings: mediation by B1 and B2 receptors J Pharmacol Exp Ther 268 1994 902 909
14. K.X. Chai, A. Ni, D. Wang, D.C. Ward, J. Chao, and L. Chao Genomic DNA sequence, expression, and chromosomal localization of the human B1 bradykinin receptor gene BDKRB1 Genomics 31 1996 51 57
15. M. Cugno, F. Salerno, M. Mandelli, E. Lorenzano, R. Paonessa, and A. Agostoni Cleavage of high molecular weight kininogen in ascites and plasma of patients with cirrhosis Thromb Res 78 1995 277 282
16. M. Cyr, T. Eastlund, C. Blais Jr., J.L. Rouleau, and A. Adam Bradykinin metabolism and hypotensive transfusion reactions Transfusion 41 2001 136 150
17. J. Damas, and A. Adam The kallikrein-kininogens-kinins system in the Brown-Norway rat Biomedicine 31 1979 249
18. S.H. Ferreira, and J.R. Vane The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat Br J Pharmacol 30 1967 417 424
19. S.L. Friedman Stellate cells: a moving target in hepatic fibrogenesis Hepatology 40 2004 1041 1043
20. L. Gioli-Pereira, J.D. Fontenele-Neto, D.R. Borges, and M. Kouyoumdjian Localization of EP24.15, a major liver kininase J Histochem Cytochem 51 2003 125 127
21. L. Gioli-Pereira, E.A. Nascimento, E.L. Santos, A. Bracht, M.A. Juliano, and J.B. Pesquero Fate of bradykinin on the rat liver when administered by the venous or arterial route J Gastroenterol Hepatol 20 2005 463 473
22. R.J. Groszmann Vasodilatation and hyperdynamic circulatory state in chronic liver disease Portal hypertension pathophysiology and treatment 1994 Blackwell Scientific Publications Oxford p.17-26
23. J. Hall Bradykinin receptors: pharmacological properties and biological roles Pharmacol Ther 56 1992 131 190
24. N. Kaufman, J.D. Page, R.A. Pixley, R. Schein, A.H. Schmaier, and R.W. Colman Alpha 2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis Blood 77 1991 2660 2667
25. M. Kouyoumdjian, D.R. Borges, E.S. Prado, and J.L. Prado Identification of receptors in the liver that mediate endocytosis of circulating tissue kallikreins Biochim Biophys Acta 980 1989 299 304
26. M. Kouyoumdjian, D.R. Borges, and J.L. Prado Kinin-inactivating endopeptidase from rat liver Int J Biochem 16 1984 733 739
27. M. Kouyoumdjian, and J. Damas The fate of plasma kallikrein in normal and kininogen-deficient rats Arch Physiol Biochem 106 1998 25 32
28. M.R. Loureiro-Silva, M. Kouyoumdjian, and D.R. Borges Plasma kallikrein and thrombin are cleared through unrelated hepatic pathways Blood Coagul Fibrinolysis 4 1993 551 554
29. M.R. Loureiro-Silva, H.M. Molina, and D.R. Borges Portal hypertensive response to bradykinin in inflamed or cirrhotic rat livers is mediated by B2-type receptors J Gastroenterol Hepatol 16 2001 41 45
30. M.R. Loureiro-Silva, H.M. Molina, and D.R. Borges The portal hypertensive response to bradykinin is mediated by the B2-type receptor and modulated by nitric oxide Hepatol Res 4 1995 175 180
31. F. Marceau, and D. Regoli Bradykinin receptor ligands: therapeutic perspectives Nat Rev Drug Discov 3 2004 845 852
32. F. Marceau, T. Sabourin, S. Houle, J.P. Fortin, E. Petitclerc, and G. Molinaro Kinin receptors: functional aspects Int Immunopharmacol 2 2002 1729 1739
33. H.S. Margolius Tissue kallikreins. Structure, regulation, and participation in mammalian physiology and desease Clin Ver Allergy Immunol 16 1998 337 349
34. B. Martins, M. Kouyoumdjian, E.A. Limaos, and D.R. Borges The clearance rate of plasma kallikrein by the liver increases during the acute-phase response to inflammation Agents Actions 37 1992 111 113
35. R.S. McCuskey, and F.D. Reilly Hepatic microvasculature: dynamic structure and its regulation Semin Liver Dis 13 1993 1 12
36. R. Medeiros, D.A. Cabrini, J. Ferreira, E.S. Fernandes, M.A. Mori, and J.B. Pesquero Bradykinin B1 receptor expression induced by tissue damage in the rat portal vein: a critical role for mitogen-activated protein kinase and nuclear factor-kappaB signaling pathways Circ Res 94 2004 1375 1382
37. J.P. Metcalf, C.A. Casey, M.F. Sorrell, and D.J. Tuma Chronic ethanol administration alters hepatic surface membranes as evidenced by decreased concanavalin A binding Proc Soc Exp Biol Med 185 1987 1 5
38. H.M. Molina, A. Carmona, M. Kouyoumdjian, D.R. Borges, and L. Juliano Liver bradykinin-inactivating-endopeptidase is similar to the metalloendopeptidase EC 3.4.24.15 Immunopharmacol 32 1996 176 179
39. T.A. Morinelli, J.G. Webb, A.A. Jaffa, P.J. Privitera, and H.S. Margolius A metabolic fragment of bradykinin, Arg-Pro-Pro-Gly-Phe, protects against the deleterious effects of lipopolysaccharide in rats J Pharmacol Exp Ther 296 2001 71 76
40. C.M. Munoz, and L.M. Leeb-Lundberg Receptor-mediated internalization of bradykinin DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways J Biol Chem 267 1992 303 309
41. M.R. Nagaoka, M. Kouyoumdjian, and D.R. Borges Hepatic clearance of tissue-type plasminogen activator and plasma kallikrein in experimental liver fibrosis Liver Int 23 2003 476 483
42. M.R. Nagaoka, M. Kouyoumdjian, and D.R. Borges The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus Braz J Med Biol Res 33 2000 119 125
43. M.R. Nagaoka, E. Strital, M. Kouyoumdjian, and D.R. Borges Participation of a galectin-dependent mechanism in the hepatic clearance of tissue-type plasminogen activator and plasma kallikkrein Thromb Res 108 2003 257 262
44. 1 receptor Biochim Biophys Acta 1442 1998 177 185
45. H. Nolly, A.O. Carretero, and A.G. Scicli Kallikrein release by vascular tissue Am J Physiol 265 1993 H1209 H1214
46. H. Ogata, M. Kouyoumdjian, and D.R. Borges Comparison between clearance rates of plasma kallikrein and of plasma kallikrein alpha-macroglobulin complexes by the liver Int J Biochem 25 1993 1047 1051
47. H. Popper Hepatocellular degeneration and death M.I. Arias W.B. Jakoby H. Popper D. Schachter D.A. Shafritz The Liver biology and pathobiology 2nd ed. 1988 Raven Press NY 1085 1103
48. 1 receptors J Cell Physiol 193 2002 275 286
49. J.L. Prado, E.A. Limaos, J. Roblero, J.O. Freitas, E.S. Prado, and A.C. Paiva Recovery and conversion of kinins in exsanguinated rat preparations Naunyn Schmiedebergs Arch Pharmacol 290 1975 191 205
50. M. Rocha e Silva, W.T. Beraldo, and G. Rosenfeld Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venom and by trypsin Am J Physiol 156 1949 261 273
51. M. Rocha e Silva A brief history of inflammation J.R. Vane S.H. Ferreira Handbook of experimental pharmacology. 50/I. Inflammation 1978 Springer Berlin 6 25
52. T. Sawamura, H. Nakada, H. Hazama, Y. Shiozaki, Y. Sameshima, and Y. Tashiro Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma Gastroenterology 87 1984 1217 1221
53. M. Schapira, C.F. Scott, and R.W. Colman Contribution of plasma protease inhibitors to the inactivation of kallikrein in the plasma J Clin Invest 69 1982 462 468
54. A.H. Schmaier The kallikrein-kinin and the rennin-angiotensin systems have a multilayered interaction Am J Physiol Regul Integr Comp Physiol 285 2003 R1 R13
55. J.A. Summerfield, J. Vergalla, and E.A. Jones Modulation of a glycoprotein recognition system on rat hepatic endothelial cells by glucose and diabetes mellitus J Clin Invest 69 1982 1337 1347
56. C.F. Toledo, and D.R. Borges Chronic administration of ethanol does not alter plasma kallikrein hepatic clearance Braz J Med Biol Res 23 1990 409 415
57. C.F. Toledo, and D.R. Borges Plasma-kallikrein clearance by the liver of acetaminophen-intoxicates rats Life Sci 52 1993 1451 1459
58. C.F. Toledo, M.R. Loureiro-Silva, H.M. Molina, V.P. Lanzoni, M. Kouyoumdjian, and D.R. Borges Plasma kallikrein clearance by the liver in experimental cirrhosis Rev Assoc Med Bras 41 1995 367 372
59. F. van der Graaf, J.A. Koedan, and B.N. Bouma Inactivation of kallikrein in human plasma J Clin Invest 71 1983 149 158
60. M.E. Webster Kallikreins in glandular tissues E.G. Erdos Bradykinin, kallidin and kallikrein 1970 Springer-Verlag Berlin 131 135
61. M.W. Wong, and J.C. Jamieson Evidence for reduced uptake of asialo-alpha 1-acid glycoprotein during the acute phase response to inflammation Life Sci 25 1979 827 833
62. G.M. Yousef, and E.P. Diamandis An overview of the kallikrein gene families in humans and other species: emerging candidate tumor markers Clin Biochem 36 2003 443 452
63. N. Yuki, M. Kubo, Y. Noro, N. Hayashi, H. Fusamoto, and A. Ito Renal kinin and kallikrein excretion in cirrhotic patients Scand J Gastroenterol 26 1991 1075 1081
64. G.X. Zhou, L. Chao, and J. Chao Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence J Biol Chem 267 1992 25873 25880